Global Expression of Molecular Transporters in the Human Vaginal Tract: Implications for HIV Chemoprophylaxis

Manjula Gunawardana, Madeline Mullen, John A. Moss, Richard Pyles, Rebecca J. Nusbaum, Jignesh Patel, Kathleen Vincent, Charles Wang, Chao Guo, Yate Ching Yuan, Charles D. Warden, Marc M. Baum

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background:Pre-exposure chemoprophylaxis (PrECP) using antiretroviral agents is a promising strategy for the prevention of sexual HIV transmission in women. Molecular transporters in the human vaginal tract (VT) may play a pivotal role in determining drug disposition and, consequently, pharmacodynamic outcomes in these efforts. Little is known, however, on the expression of these transporters in vaginal tissues, representing a critical knowledge gap.Methodology/Principal Findings:Our study analyzed the genome-wide transcriptome in 44 vaginal tissue samples from 6 reproductive-age women undergoing gynecologic surgeries. The analysis revealed that, unexpectedly, a large number (43%) of gene isoforms corresponding to membrane transporters were over-expressed (above the median expression level) in all samples. A subset of 12 highly expressed membrane transporters was identified and contained 10 members (83%) of the solute carrier superfamily. The largest difference in membrane transporter gene expression was observed across subjects, but more subtle differential expression also was found along the anterior-posterior axis of the VT. Cross-validation of the microarray analyses with measurements RT-qPCR demonstrated high concordance between these data sets. Immunofluorescence labeling of membrane transporter proteins in vaginal tissues was highly dependent on tissue/cell types.Conclusions/Significance:Antiretroviral PrECP drugs currently under evaluation are substrates for molecular transporters that were commonly expressed, but fell into both over- or under-expressed categories in all samples, suggesting a complex role for carrier-mediated processes in determining the disposition of these xenobiotics in vaginal tissues. These findings hold important implications for the successful development of products, either oral or intravaginal, for female-controlled HIV PrECP.

Original languageEnglish (US)
Article numbere77340
JournalPLoS One
Volume8
Issue number10
DOIs
StatePublished - Oct 15 2013

Fingerprint

chemoprevention
Chemoprevention
Membrane Transport Proteins
transporters
HIV
Tissue
Genes
Pharmacodynamics
Anti-Retroviral Agents
Gynecologic Surgical Procedures
Xenobiotics
Microarray Analysis
Microarrays
Transcriptome
Gene expression
Pharmaceutical Preparations
Surgery
Labeling
drugs
Fluorescent Antibody Technique

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Global Expression of Molecular Transporters in the Human Vaginal Tract : Implications for HIV Chemoprophylaxis. / Gunawardana, Manjula; Mullen, Madeline; Moss, John A.; Pyles, Richard; Nusbaum, Rebecca J.; Patel, Jignesh; Vincent, Kathleen; Wang, Charles; Guo, Chao; Yuan, Yate Ching; Warden, Charles D.; Baum, Marc M.

In: PLoS One, Vol. 8, No. 10, e77340, 15.10.2013.

Research output: Contribution to journalArticle

Gunawardana, M, Mullen, M, Moss, JA, Pyles, R, Nusbaum, RJ, Patel, J, Vincent, K, Wang, C, Guo, C, Yuan, YC, Warden, CD & Baum, MM 2013, 'Global Expression of Molecular Transporters in the Human Vaginal Tract: Implications for HIV Chemoprophylaxis', PLoS One, vol. 8, no. 10, e77340. https://doi.org/10.1371/journal.pone.0077340
Gunawardana, Manjula ; Mullen, Madeline ; Moss, John A. ; Pyles, Richard ; Nusbaum, Rebecca J. ; Patel, Jignesh ; Vincent, Kathleen ; Wang, Charles ; Guo, Chao ; Yuan, Yate Ching ; Warden, Charles D. ; Baum, Marc M. / Global Expression of Molecular Transporters in the Human Vaginal Tract : Implications for HIV Chemoprophylaxis. In: PLoS One. 2013 ; Vol. 8, No. 10.
@article{7629645f65654d64b85c254ef4008cb1,
title = "Global Expression of Molecular Transporters in the Human Vaginal Tract: Implications for HIV Chemoprophylaxis",
abstract = "Background:Pre-exposure chemoprophylaxis (PrECP) using antiretroviral agents is a promising strategy for the prevention of sexual HIV transmission in women. Molecular transporters in the human vaginal tract (VT) may play a pivotal role in determining drug disposition and, consequently, pharmacodynamic outcomes in these efforts. Little is known, however, on the expression of these transporters in vaginal tissues, representing a critical knowledge gap.Methodology/Principal Findings:Our study analyzed the genome-wide transcriptome in 44 vaginal tissue samples from 6 reproductive-age women undergoing gynecologic surgeries. The analysis revealed that, unexpectedly, a large number (43{\%}) of gene isoforms corresponding to membrane transporters were over-expressed (above the median expression level) in all samples. A subset of 12 highly expressed membrane transporters was identified and contained 10 members (83{\%}) of the solute carrier superfamily. The largest difference in membrane transporter gene expression was observed across subjects, but more subtle differential expression also was found along the anterior-posterior axis of the VT. Cross-validation of the microarray analyses with measurements RT-qPCR demonstrated high concordance between these data sets. Immunofluorescence labeling of membrane transporter proteins in vaginal tissues was highly dependent on tissue/cell types.Conclusions/Significance:Antiretroviral PrECP drugs currently under evaluation are substrates for molecular transporters that were commonly expressed, but fell into both over- or under-expressed categories in all samples, suggesting a complex role for carrier-mediated processes in determining the disposition of these xenobiotics in vaginal tissues. These findings hold important implications for the successful development of products, either oral or intravaginal, for female-controlled HIV PrECP.",
author = "Manjula Gunawardana and Madeline Mullen and Moss, {John A.} and Richard Pyles and Nusbaum, {Rebecca J.} and Jignesh Patel and Kathleen Vincent and Charles Wang and Chao Guo and Yuan, {Yate Ching} and Warden, {Charles D.} and Baum, {Marc M.}",
year = "2013",
month = "10",
day = "15",
doi = "10.1371/journal.pone.0077340",
language = "English (US)",
volume = "8",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "10",

}

TY - JOUR

T1 - Global Expression of Molecular Transporters in the Human Vaginal Tract

T2 - Implications for HIV Chemoprophylaxis

AU - Gunawardana, Manjula

AU - Mullen, Madeline

AU - Moss, John A.

AU - Pyles, Richard

AU - Nusbaum, Rebecca J.

AU - Patel, Jignesh

AU - Vincent, Kathleen

AU - Wang, Charles

AU - Guo, Chao

AU - Yuan, Yate Ching

AU - Warden, Charles D.

AU - Baum, Marc M.

PY - 2013/10/15

Y1 - 2013/10/15

N2 - Background:Pre-exposure chemoprophylaxis (PrECP) using antiretroviral agents is a promising strategy for the prevention of sexual HIV transmission in women. Molecular transporters in the human vaginal tract (VT) may play a pivotal role in determining drug disposition and, consequently, pharmacodynamic outcomes in these efforts. Little is known, however, on the expression of these transporters in vaginal tissues, representing a critical knowledge gap.Methodology/Principal Findings:Our study analyzed the genome-wide transcriptome in 44 vaginal tissue samples from 6 reproductive-age women undergoing gynecologic surgeries. The analysis revealed that, unexpectedly, a large number (43%) of gene isoforms corresponding to membrane transporters were over-expressed (above the median expression level) in all samples. A subset of 12 highly expressed membrane transporters was identified and contained 10 members (83%) of the solute carrier superfamily. The largest difference in membrane transporter gene expression was observed across subjects, but more subtle differential expression also was found along the anterior-posterior axis of the VT. Cross-validation of the microarray analyses with measurements RT-qPCR demonstrated high concordance between these data sets. Immunofluorescence labeling of membrane transporter proteins in vaginal tissues was highly dependent on tissue/cell types.Conclusions/Significance:Antiretroviral PrECP drugs currently under evaluation are substrates for molecular transporters that were commonly expressed, but fell into both over- or under-expressed categories in all samples, suggesting a complex role for carrier-mediated processes in determining the disposition of these xenobiotics in vaginal tissues. These findings hold important implications for the successful development of products, either oral or intravaginal, for female-controlled HIV PrECP.

AB - Background:Pre-exposure chemoprophylaxis (PrECP) using antiretroviral agents is a promising strategy for the prevention of sexual HIV transmission in women. Molecular transporters in the human vaginal tract (VT) may play a pivotal role in determining drug disposition and, consequently, pharmacodynamic outcomes in these efforts. Little is known, however, on the expression of these transporters in vaginal tissues, representing a critical knowledge gap.Methodology/Principal Findings:Our study analyzed the genome-wide transcriptome in 44 vaginal tissue samples from 6 reproductive-age women undergoing gynecologic surgeries. The analysis revealed that, unexpectedly, a large number (43%) of gene isoforms corresponding to membrane transporters were over-expressed (above the median expression level) in all samples. A subset of 12 highly expressed membrane transporters was identified and contained 10 members (83%) of the solute carrier superfamily. The largest difference in membrane transporter gene expression was observed across subjects, but more subtle differential expression also was found along the anterior-posterior axis of the VT. Cross-validation of the microarray analyses with measurements RT-qPCR demonstrated high concordance between these data sets. Immunofluorescence labeling of membrane transporter proteins in vaginal tissues was highly dependent on tissue/cell types.Conclusions/Significance:Antiretroviral PrECP drugs currently under evaluation are substrates for molecular transporters that were commonly expressed, but fell into both over- or under-expressed categories in all samples, suggesting a complex role for carrier-mediated processes in determining the disposition of these xenobiotics in vaginal tissues. These findings hold important implications for the successful development of products, either oral or intravaginal, for female-controlled HIV PrECP.

UR - http://www.scopus.com/inward/record.url?scp=84885450494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885450494&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0077340

DO - 10.1371/journal.pone.0077340

M3 - Article

C2 - 24143220

AN - SCOPUS:84885450494

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 10

M1 - e77340

ER -